10x Genomics director John R. Stuelpnagel sells 20,000 shares worth $1.15 million

• 10x Genomics director John R. Stuelpnagel sold 20,000 Class A common shares on Aug. 11, 2026.
• Sales priced at USD 57.58 to USD 58.73 per share.
• Directly held stake fell to 348,436 shares following the transactions.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. 10x Genomics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001610717-26-000358), on August 13, 2026, and is solely responsible for the information contained therein.